Abstract
Panelists (Industry Representatives): Dr Suzanne Streichenwein, Drug Safety, Hoechst AG Medical Department, Frankfurt, West Germany; Dr Michel Auriche, Head of Drug Safety Department, Medical and Scientific Development, Rhone-Poulene Sante, Les Miroirs, France; Dr Jan Venulet, Ciba-Geigy Medical Department, Basle, Switzerland; Dr J. Richard Crout, Boehringer Mannheim, Rockville, Maryland (Regulatory Representatives): Dr Bengt-Erik Wiholm, National Board of Health and Welfare, Department of Drugs, Uppsala, Sweden; and Dr Bernard Begaud, University of Bordeaux, Bordeaux Cedex, France
Get full access to this article
View all access options for this article.